Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1979 Jun;32(6):534–537. doi: 10.1136/jcp.32.6.534

Reactogenicity and immunogenicity of a surface-antigen-adsorbed influenza virus vaccine in children.

L M Eastwood, R Jennings, R D Milner, C W Potter
PMCID: PMC1145733  PMID: 469010

Abstract

An influenza virus vaccine containing the purified surface haemagglutinin and neuraminidase antigens of A/Victoria/75 and B/Hong Kong/73 viruses adsorbed to an aluminium hydroxide gel was assessed for reactogenicity and immunogenicity in children aged 4 to 11 years, since there is no influenza virus vaccine available for this age group. Significant serum haemagglutination-inhibiting antibody responses to the A/Victoria/75 and B/Hong Kong/73 haemagglutinin antigens present in the vaccine were observed in 47% and 35%, respectively, of the children vaccinated, with a single dose. The vaccine induced no significant local or systemic reactions.

Full text

PDF
534

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aymard-Henry M., Coleman M. T., Dowdle W. R., Laver W. G., Schild G. C., Webster R. G. Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ. 1973;48(2):199–202. [PMC free article] [PubMed] [Google Scholar]
  2. Barry D. W., Mayner R. E., Hochstein H. D., Dunlap R. C., Rastogi S. C., Hannah J. E., Blackburn R. J., Sullivan J. L., Gerety R. J. Comparative trial of influenza vaccines. II. Adverse reactions in children and adults. Am J Epidemiol. 1976 Jul;104(1):47–59. doi: 10.1093/oxfordjournals.aje.a112273. [DOI] [PubMed] [Google Scholar]
  3. Bevan A. M., Furminger I. G., Smith C. H. Neuraminidase assay of influenza vaccines. Dev Biol Stand. 1975;28:173–180. [PubMed] [Google Scholar]
  4. Brady M. I., Furminger I. G. A surface antigen influenza vaccine. 1. Purification of haemagglutinin and neuraminidase proteins. J Hyg (Lond) 1976 Oct;77(2):161–172. doi: 10.1017/s002217240002458x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brandon F. B., Barrett C. D., Jr, Hook A. E., Lease G. O. Human febrile response to influenza virus or its ether isolated hemagglutinins. Proc Soc Exp Biol Med. 1967 Jul;125(3):683–686. doi: 10.3181/00379727-125-32180. [DOI] [PubMed] [Google Scholar]
  6. DAVENPORT F. M., HENNESSY A. V., BRANDON F. M., WEBSTER R. G., BARRETT C. D., Jr, LEASE G. O. COMPARISONS OF SEROLOGIC AND FEBRILE RESPONSES IN HUMANS TO VACCINATION WITH INFLUENZA A VIRUSES OR THEIR HEMAGGLUTININS. J Lab Clin Med. 1964 Jan;63:5–13. [PubMed] [Google Scholar]
  7. Gross P. A., Ennis F. A., Gaerlan P. F., Denson L. J., Denning C. R., Schiffman D. A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. J Infect Dis. 1977 Nov;136(5):623–632. doi: 10.1093/infdis/136.5.623. [DOI] [PubMed] [Google Scholar]
  8. Gross P. A., Ennis F. A. Influenza vaccine: split-product versus whole-virus types--How do they differ. N Engl J Med. 1977 Mar 10;296(10):567–568. doi: 10.1056/NEJM197703102961012. [DOI] [PubMed] [Google Scholar]
  9. Hobson D., Curry R. L., Beare A. S., Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972 Dec;70(4):767–777. doi: 10.1017/s0022172400022610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Marine W. M., Stuart-Harris C. Reactions and serologic responses in young children and infants after administration of inactivated monovalent influenza A vaccine. J Pediatr. 1976 Jan;88(1):26–30. doi: 10.1016/s0022-3476(76)80721-4. [DOI] [PubMed] [Google Scholar]
  11. Monto A. S., Kendal A. P. Effect of neuraminidase antibody on Hong Kong influenza. Lancet. 1973 Mar 24;1(7804):623–625. doi: 10.1016/s0140-6736(73)92196-x. [DOI] [PubMed] [Google Scholar]
  12. Oxford J. S., Schild G. C. Quantification of influenza virus structural proteins using rocket immunoelectrophoresis. J Gen Virol. 1978 Jan;38(1):187–193. doi: 10.1099/0022-1317-38-1-187. [DOI] [PubMed] [Google Scholar]
  13. Phillips C. F., Phillips C. A., Hodgkin W. E., Forsyth B. R., Rubin B. A., Geraghty M. E. Killed subunit influenza vaccine in children. Pediatrics. 1973 Sep;52(3):416–419. [PubMed] [Google Scholar]
  14. Potter C. W., Jennings R., McLaren C., Edey D., Stuart-Harris C. H., Brady M. A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group. J Hyg (Lond) 1975 Dec;75(3):353–362. doi: 10.1017/s0022172400024414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Potter C. W., Jennings R., Phair J. P., Clarke A., Stuart-Harris C. H. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine. J Infect Dis. 1977 Mar;135(3):423–431. doi: 10.1093/infdis/135.3.423. [DOI] [PubMed] [Google Scholar]
  16. SEVER J. L. Application of a microtechnique to viral serological investigations. J Immunol. 1962 Mar;88:320–329. [PubMed] [Google Scholar]
  17. Schevill S., Marks M. I. Adverse reactions to 1975 bivalent influenza vaccine in children. Can Med Assoc J. 1977 Feb 5;116(3):271–272. [PMC free article] [PubMed] [Google Scholar]
  18. Wright P. F., Sell S. H., Thompson J., Karzon D. T. Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants. J Pediatr. 1976 Jan;88(1):31–35. doi: 10.1016/s0022-3476(76)80722-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES